Zixin Tao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zixin Tao has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Beier Chen
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China
1 shared publicationBo Situ
Department of Laboratory Medicine Nanfang Hospital, Southern Medical University Guangzhou Guangdong China
1 shared publicationChao Sheng
Department of Obstetrics and Gynecology Nanfang Hospital, Southern Medical University Guangzhou Guangdong China
1 shared publicationDongni Wen
Department of Obstetrics and Gynecology Nanfang Hospital, Southern Medical University Guangzhou Guangdong China
1 shared publicationFang He
Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
1 shared publicationHaoyue Hu
Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
1 shared publication
Latest Publications
- Open Access
- 15 June 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (3) , e0007623
Alterations in the Gut Microbiome and Metabolisms in Pregnancies with Fetal Growth Restriction
Downstream of the primary cause of fetal growth restriction are placental insufficiency and fetal malnutrition. Gut microbiota and metabolites appear to play an important role in the progression of gestation, while dysbiosis induces maternal and fetal complications.
- 15 June 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (3) , e0007623
Open AccessAlterations in the Gut Microbiome and Metabolisms in Pregnancies with Fetal Growth Restriction
Downstream of the primary cause of fetal growth restriction are placental insufficiency and fetal malnutrition. Gut microbiota and metabolites appear to play an important role in the progression of gestation, while dysbiosis induces maternal and fetal complications.
- Top Cited PapersOpen Access
- 11 May 2023
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 12 (5) , e12328
Extracellular vesicles derived from Akkermansia muciniphila promote placentation and mitigate preeclampsia in a mouse model
Preeclampsia (PE) is a multisystem disorder with high maternal morbidity and mortality rates. Currently, no practical therapeutic approach is available to prevent PE progression, except for early delivery. Gut dysbiosis is associated with PE development. Previous data showed that the abundance of Akkermansia muciniphila (Am) was lower in patients with PE than in normotensive pregnant women. Here, in this study, decreased abundance of Am was observed in a PE mouse model. Also, we found that administration with Am could significantly attenuate systolic blood pressure, promote foetal growth and improve the placental pathology in mice with PE. Moreover, Am‐derived extracellular vesicles (AmEVs) were transferred from the gastrointestinal (GI) tract to the placenta and mitigated pre‐eclamptic symptoms in PE mice. These beneficial effects of AmEVs were mediated by enhanced trophoblast invasion of the spiral artery (SpA) and SpA remodelling through activation of the epidermal growth factor receptor (EGFR)–phosphatidylinositol‐3‐kinase (PI3K)–protein kinase B (AKT) signalling pathway. Collectively, our findings revealed the potential benefit of using AmEVs for PE treatment and highlighted important host–microbiota interactions.
- 11 May 2023
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 12 (5) , e12328
Top Cited PapersOpen AccessExtracellular vesicles derived from Akkermansia muciniphila promote placentation and mitigate preeclampsia in a mouse model
Preeclampsia (PE) is a multisystem disorder with high maternal morbidity and mortality rates. Currently, no practical therapeutic approach is available to prevent PE progression, except for early delivery. Gut dysbiosis is associated with PE development. Previous data showed that the abundance of Akkermansia muciniphila (Am) was lower in patients with PE than in normotensive pregnant women. Here, in this study, decreased abundance of Am was observed in a PE mouse model. Also, we found that administration with Am could significantly attenuate systolic blood pressure, promote foetal growth and improve the placental pathology in mice with PE. Moreover, Am‐derived extracellular vesicles (AmEVs) were transferred from the gastrointestinal (GI) tract to the placenta and mitigated pre‐eclamptic symptoms in PE mice. These beneficial effects of AmEVs were mediated by enhanced trophoblast invasion of the spiral artery (SpA) and SpA remodelling through activation of the epidermal growth factor receptor (EGFR)–phosphatidylinositol‐3‐kinase (PI3K)–protein kinase B (AKT) signalling pathway. Collectively, our findings revealed the potential benefit of using AmEVs for PE treatment and highlighted important host–microbiota interactions.